The nucleotide analogue 3-deazaadenosine prevents neointima-formation after balloon injury

Biochem Biophys Res Commun. 2009 Jan 23;378(4):826-31. doi: 10.1016/j.bbrc.2008.11.151. Epub 2008 Dec 12.

Abstract

We have recently shown that 3-deazaadenosine (c3Ado) inhibits atherogenesis in mice. We studied whether its anti-inflammatory capacity would also affect neointima-formation after balloon injury. Sprague Dawley rats underwent balloon angioplasty. C3Ado was administered orally, starting 5 days prior to the balloon injury and continued for 2 weeks. Fourteen days after balloon injury the intima/media ratio in the c3Ado-treated group was reduced by 67% (p<0.001) and luminal stenosis by 50% (p<0.001). Neointimal cellular density was decreased by 25% (p<0.001) and the induction of c-Jun and ki67 was markedly lower. The reduction of the intima/media ratio was still observed 3 months after balloon injury. Furthermore, a c3Ado-dependent inhibition of PDGF-mediated ERK-activation and proliferation could be demonstrated. Short-term administration of C3Ado inhibits neointima-formation in rats for at least 3 months after injury. The present findings implicate that c3Ado may be useful as an inhibitor of restenosis-formation after balloon angioplasty in humans.

MeSH terms

  • Administration, Oral
  • Angioplasty, Balloon / adverse effects*
  • Animals
  • Bone Marrow / drug effects
  • Cell Proliferation / drug effects
  • Coronary Restenosis / pathology
  • Coronary Restenosis / prevention & control*
  • Extracellular Signal-Regulated MAP Kinases / metabolism
  • Liver / drug effects
  • Male
  • Phosphorylation / drug effects
  • Rats
  • Rats, Sprague-Dawley
  • Tubercidin / administration & dosage*
  • Tubercidin / adverse effects
  • Tunica Intima / drug effects*
  • Tunica Intima / injuries
  • Tunica Intima / pathology

Substances

  • 3-deazaadenosine
  • Extracellular Signal-Regulated MAP Kinases
  • Tubercidin